• Home
  • Most neoadjuvant chemotherapy for triple-negative breast cancer should include platinum.

Most neoadjuvant chemotherapy for triple-negative breast cancer should include platinum.

Author List
Dent R, Rugo HS
Publication
The Lancet. Oncology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/165307513
Publication Year
2021
PubMed ID
33387495
Publication Title
Dent R, Rugo HS. Most neoadjuvant chemotherapy for triple-negative breast cancer should include platinum. Lancet Oncol. 2021 01; 22(1):27-28.